Taysha Gene Therapies (TSHA) Q4 2024 Earnings

Nov 13Confirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.16
-0.02
0.12
0.26

Details

Expected EPS
-0.086725
Actual EPS
-0.1
Surprise EPS
-0.01
Surprise Percent
-15.31%

Description

⁨Taysha Gene Therapies⁩ (⁦TSHA⁩) has reported earnings of ⁦-0.1⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts